Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 922,733
  • Shares Outstanding, K 37,540
  • Annual Sales, $ 0 K
  • Annual Income, $ -71,890 K
  • 36-Month Beta 0.91
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.68 +12.14%
on 02/06/18
25.37 -8.59%
on 01/17/18
-1.84 (-7.35%)
since 01/16/18
3-Month
20.68 +12.14%
on 02/06/18
27.49 -15.64%
on 11/27/17
-0.47 (-1.99%)
since 11/16/17
52-Week
16.51 +40.46%
on 06/15/17
32.25 -28.09%
on 10/06/17
+3.91 (+20.28%)
since 02/16/17

Most Recent Stories

More News
Flexion Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President, Commercial Operations, will participate...

FLXN : 23.19 (-5.66%)
Promising New Approaches in Pain Management

NEW YORK, February 1, 2018 /PRNewswire/ --

CARA : 14.48 (-2.43%)
PREV.CN : 0.420 (-4.55%)
ACRX : 1.90 (+8.57%)
PRVCF : 0.2500 (-31.58%)
FLXN : 23.19 (-5.66%)
NKTR : 83.43 (+1.57%)
Thermo Fisher Scientific Designs Flexible Manufacturing Site for Flexion Therapeutics, Inc.

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that manufacturing of Zilretta(TM), is underway at its Swindon, U.K. site where a custom "condo" manufacturing suite...

FLXN : 23.19 (-5.66%)
Generic Drugs Stocks' Research Reports Released on Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Allergan

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on CPRX, FLXN, SUPN, and AGN which can be accessed for free by signing up to www.wallstequities.com/registration....

SUPN : 38.35 (-2.04%)
AGN : 164.04 (-0.26%)
CPRX : 3.43 (-2.83%)
FLXN : 23.19 (-5.66%)
Flexion Therapeutics Enrolls First Patient in Study Evaluating the Pharmacokinetics and Safety of ZILRETTA(TM) (triamcinolone acetonide extended-release injectable suspension) in Osteoarthritis of the Shoulder and Hip

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it has enrolled the first patient in a clinical trial to evaluate the pharmacokinetics and safety of ZILRETTA (triamcinolone acetonide extended-release...

FLXN : 23.19 (-5.66%)
Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee

-- Acquisition complements existing portfolio with an innovative, locally administered therapeutic intended to provide persistent effective concentrations of IL-1Ra in the knee for at least a year

FLXN : 23.19 (-5.66%)
Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as Chief Medical Officer

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Scott Kelley, M.D., has been named Chief Medical Officer. Dr. Kelley previously served as the company's Vice President of Medical Affairs,...

FLXN : 23.19 (-5.66%)
Flexion Therapeutics Enrolls First Patient in Phase 2 Pharmacokinetics and Safety Study of ZILRETTA(TM) (triamcinolone acetonide extended-release injectable suspension) in Bilateral Osteoarthritis of the Knee

Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today the enrollment of the first patient in a clinical trial to evaluate the pharmacokinetics (PK) and safety of concurrent injections of ZILRETTA (triamcinolone...

FLXN : 23.19 (-5.66%)
Flexion Therapeutics to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, and Dan Deardorf, Senior Vice President, Commercial Operations, will participate...

FLXN : 23.19 (-5.66%)
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to three new employees for an aggregate of 20,500 shares of common stock. The Compensation Committee of the...

FLXN : 23.19 (-5.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Business Summary

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United...

See More

Key Turning Points

2nd Resistance Point 25.28
1st Resistance Point 24.24
Last Price 23.19
1st Support Level 22.66
2nd Support Level 22.12

See More

52-Week High 32.25
Fibonacci 61.8% 26.24
Fibonacci 50% 24.38
Last Price 23.19
Fibonacci 38.2% 22.52
52-Week Low 16.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.